Liang X et al.
Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)
J Hematol Oncology 2018 11(1)
doi: 10.1186/s13045-018-0670-9